A case of parvovirus B19-associated fulminant myocarditis in an infant successfully treated with immunosuppressive therapy
- PMID: 36099078
- DOI: 10.2459/JCM.0000000000001358
A case of parvovirus B19-associated fulminant myocarditis in an infant successfully treated with immunosuppressive therapy
References
-
- Law YM, Lal AK, Chen S, et al. American Heart Association Pediatric Heart Failure and Transplantation Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young and Stroke Council. Diagnosis and management of myocarditis in children: a scientific statement from the American Heart Association. Circulation 2021; 144:e123–e135.
-
- Matsuura H, Ichida F, Saji T, et al. Clinical features of acute and fulminant myocarditis in children: 2nd Nationwide Survey by Japanese Society of Pediatric Cardiology and Cardiac Surgery. Circ J 2016; 80:2362–2368.
-
- Arola A, Pikkarainen E, Sipilä JO, et al. Occurrence and features of childhood myocarditis: a nationwide study in Finland. J Am Heart Assoc 2017; 6:e005306.
-
- Veronese G, Cipriani M, Bottiroli M, et al. Fulminant myocarditis triggered by OC43 subtype coronavirus: a disease deserving evidence-based care bundles. J Cardiovasc Med (Hagerstown) 2020; 21:529–531.
-
- Tschöpe C, Ammirati E, Bozkurt B, et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol 2021; 18:169–193.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources